Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21252171 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)
Conditions: Diabetes Mellitus;   Coronary Artery Disease
Interventions: Drug: prasugrel;   Drug: Clopidogrel
2 Completed Multiple Electrode Aggregometry & Clopidogrel Resistance
Conditions: Type 2 Diabetes Mellitus (T2DM);   Coronary Artery Disease (CAD);   Myocardial Infraction

Study has passed its completion date and status has not been verified in more than two years.